Leukocytosis, vascular disease, and adenine nucleotide metabolism [8]

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 26, Issue 2, 2006, Pages

  Heptinstall, Stan ^a   Glenn, Jacqueline R ^a   Johnson, Andrew ^a   Myers, Bethan ^a   White, Ann E ^a   Zhao, Lian ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE DIPHOSPHATE; ADENOSINE DIPHOSPHATE ANTAGONIST; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ANTICOAGULANT AGENT; CD39 ANTIGEN; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ATHEROSCLEROSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LETTER; LEUKOCYTOSIS; LEUKOPENIA; MORBIDITY; MORTALITY; NEUTROPHIL; NUCLEOTIDE METABOLISM; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SYSTEMATIC REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOSIS; VASCULAR DISEASE; IMMUNOLOGY; METABOLISM; NOTE;

ADENOSINE DIPHOSPHATE; HUMANS; LEUKOCYTOSIS; VASCULAR DISEASES;

EID: 33644872211     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000197801.28944.41     Document Type: Letter

References (11)

1. Coller BS. Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene? Arterioscler Thromb Vasc Biol. 2005;25:658-670.
2. Kaski JC, Avanzas P, Arroyo-Espliguero R. Neutrophil count and complex lesions in patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2005;25:e112.
3. Coller BS. Neutrophil count and complex lesions in patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2005;25:e112.
4. Grzybowski M, Welch RD, Parsons L, Ndumele CE, Chen E, Zalenski R, Barron HV. The association between white blood cell count and acute myocardial infarction in-hospital mortality: findings from the National-Registry of Myocardial Infarction. Acad Emerg Med. 2004;11:1049-1060.
5. Gurm HS, Bhatt DL, Gupta R, Ellis SG, Topol EJ, Lauer MS. Preprocedural white blood cell count and death after percutaneous coronary intervention. Am Heart J. 2003;146:692-698.
6. Hacke W. From CURE to MATCH: ADP receptor antagonists as the treatment of choice for high-risk atherothrombotic patients. Cerebrovasc Dis,. 2002;13:22-26.
7. Coade SB, Pearson JD. Metabolism of adenine nucleotides in human blood. Circ Res. 1989;65:531-537.
8. Stafford NP, Pink AE, White AE, Glenn JR, Heptinstall S. Mechanisms involved in adenosine triphosphate-induced platelet aggregation in whole blood. Arterioscler Thromb Vasc Biol. 2003;23:1928-1933.
9. Glenn JR, White AE, Johnson A, Fox SC, Behan MWH, Dolan G, Heptinstall S. Leukocyte count and leukocyte ecto-nucleotidase are major determinants of the effects of adenosine triphosphate and adenosine diphosphate on platelet aggregation in human blood. Platelets. 2005;16:159-170.
10. Heptinstall S, Johnson A, Glenn JR, White AE. Adenine nucleotide metabolism in human blood - important roles for leukocytes and erythrocytes. J Thromb Haemost. 2005;3:2331-2339.
11. Wang L, Olivecrona G, Götberg M, Olsson ML, Winzell MS, Erlinge D. ADP acting on P2Y13 receptors is a negative feedback pathway for ATP release from human red blood cells. Circ Res. 2005;96:189-196.